MSI1 Accelerates Prostate Cancer Cell Proliferation, Migration and Glycolysis by Promoting ABHD2 Transcription
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Musashi-1 (MSI1) promotes prostate cancer (PCa) progression by increasing ABHD2 transcription, leading to enhanced proliferation, migration, and glycolysis. Targeting MSI1 offers a new therapeutic strategy for PCa treatment.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Musashi-1 (MSI1) is a potential prognostic biomarker in prostate cancer (PCa), but its precise role and molecular mechanisms in PCa progression are not fully understood.
- Investigating the relationship between MSI1 and other molecules involved in PCa pathogenesis is crucial for identifying therapeutic targets.
Purpose Of The Study
- To elucidate the role of Musashi-1 (MSI1) in prostate cancer (PCa) progression.
- To investigate the molecular mechanisms by which MSI1 influences PCa cell behavior and glycolysis.
- To determine if ABHD2 is a downstream target of MSI1 in PCa.
Main Methods
- Quantitative real-time PCR (qRT-PCR) and western blot to assess MSI1 and ABHD2 expression.
- Cell proliferation (EdU assay), cell cycle (flow cytometry), apoptosis, and migration (Transwell assay) assays.
- Glycolysis assessment (glucose uptake, lactate production), dual-luciferase reporter assay, and ChIP assay to evaluate molecular interactions and transcriptional regulation.
Main Results
- MSI1 expression was significantly upregulated in PCa tissues and cells.
- MSI1 downregulation inhibited PCa cell proliferation, migration, and glycolysis, while enhancing apoptosis.
- MSI1 directly activated ABHD2 transcription, leading to increased ABHD2 expression, which in turn promoted PCa progression. MSI1 interference reduced tumor growth in vivo by decreasing ABHD2 levels.
Conclusions
- MSI1 promotes prostate cancer (PCa) cell proliferation, migration, and glycolysis by activating ABHD2 transcription.
- MSI1-ABHD2 axis represents a novel therapeutic target for prostate cancer treatment.
- Understanding MSI1's role provides insights into PCa progression and potential therapeutic strategies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...